Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
MDGL
MDGL
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MDGL News
MDGL Stock Rises Significantly in a Month Amid Eli Lilly Acquisition Rumors
4d ago
stocktwits
Wall Street Declines Amid Rising U.S.-Iran Tensions
4d ago
seekingalpha
Madrigal Pharmaceuticals Shares Surge 12% Amid Takeover Speculation
4d ago
seekingalpha
U.S. Markets Declined on Thursday; Karman Holdings Experienced Largest Loss
4d ago
Barron's
Summit Therapeutics Faces FDA Review Risk for Ivonescimab
5d ago
Fool
Summit Therapeutics Faces FDA Approval Risk for Ivonescimab
5d ago
NASDAQ.COM
Avaí Bio Initiates Key Cell Bank Project for Therapy Development
6d ago
PRnewswire
Avaí Bio Initiates Key Cell Bank Project for Therapy Development
6d ago
Newsfilter
RTW Investments Takes New Stake in Apellis Pharmaceuticals
Mar 22 2026
Yahoo Finance
RTW Investments Increases Stake in Cogent Biosciences by $116 Million
Mar 22 2026
Yahoo Finance
Undervalued Investment Opportunities: Axsome and Madrigal
Mar 10 2026
Fool
Axsome and Madrigal's Market Potential
Mar 10 2026
NASDAQ.COM
Madrigal (MDGL) Q4 2025 Earnings Call Transcript
Feb 23 2026
NASDAQ.COM
Baker Bros. Advisors Increases Stake in Kymera Therapeutics
Feb 23 2026
Yahoo Finance
U.S. Markets Fell on Thursday; Klarna Group Reported Largest Loss
Feb 19 2026
Barron's
Madrigal Pharmaceuticals Q4 2025 Earnings Call Highlights
Feb 19 2026
seekingalpha
Show More News
